Gyros Protein Technologies introduces multi-species kit for toxicokinetic studies

Gyrolab Generic TK Kit for early-stage biotherapeutic development, optimized for use in Gyrolab systems Uppsala, Sweden: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today it has introduced a new reagent kit for early-stage biotherapeutic toxicokinetic (TK) studies. The new Gyrolab® Generic TK Kit adds to a growing [...]

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

Lightning-Link is now available in volumes from 10µg to 100mg Direct-labeling technology provides excellent batch-to-batch consistency and high performance Bulk supply of ultra-high quality Lightning-Link raw materials also now available Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today [...]

SYNGENTA AND NRGENE EXPAND COLLABORATION AS SYNGENTA SIGNS LONG-TERM LICENSING OF GENOMAGIC

Collaboration to have disruptive impact on the world food supply Research Triangle Park, North Carolina, & Ness Ziona, Israel – Syngenta, a global leading agrochemical and seed company, and NRGene, the premier genomic big data company, have continued to advance their cooperation in breeding and trait discovery in key crops. Syngenta has licensed NRGene’s GenoMAGICTM, a cloud-based big data [...]

Vironova Biosafety AB passed SWEDAC inspection without remarks

Vironova Biosafety specializes in performing viral clearance studies for biological drugs and is the only Nordic CRO that conducts these studies in BSLII and BSLIII certified cell and virus laboratories in compliance with good laboratory practices (GLP). Services range from early R&D to market release and theoretical viral risk assessment is offered by experts with [...]

ANOTHER LARGE PHARMA IMPLEMENTS BERKELEY LIGHTS’ BEACON® OPTOFLUIDIC PLATFORM FOR ACCELERATING ANTIBODY DISCOVERY

Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Novartis is implementing BLI’s Beacon platform to help accelerate their antibody discovery workflow. Novartis was an early adopter of the BLI technology and the results from this early work has culminated in the [...]

Closing of Biotage’s acquisition of Horizon Technology

Stockholm – Biotage AB (Biotage), (NASDAQ OMX Stockholm: BIOT.ST) today announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, Inc. (Horizon) based in New Hampshire, US, in accordance with contract and public announcement of December 6th, 2017. The purchase price adjusted for actual net cash at the [...]

Thermo Fisher Scientific Announces More Than 30 Orders for Ion GeneStudio S5 One Week After Debut

CARLSBAD, Calif. -- Thermo Fisher Scientific today announced it has received more than 30 orders for multiple Ion GeneStudio S5 Systems a week after launching the new line of benchtop next-generation sequencing (NGS) instruments. The sequencers have been purchased by early access laboratories for application areas ranging from cancer research to metagenomics. "We are very excited to start [...]

Genevac: Efficient Concentration of Nucleic Acids

The miVac DNA centrifugal sample concentrator from Genevac is purpose designed to efficiently remove water and organic solvents from biological samples containing nucleic acids. The compact benchtop system includes a built-in high-performance vacuum pump, concentration chamber with electromagnetic drive for quiet, maintenance-free operation, and a fixed aluminium rotor for microcentrifuge tubes. To use your miVac [...]

Perten Instruments Moves North American Headquarters to Larger Facility

Business Growth Results in Need for Larger Offices and Training Facilities Perten Instruments, a PerkinElmer company, has relocated its North American headquarters to a new facility in order to meet the demands of its growing business in dairy, grain, and food. “We were at our previous facility for more than 20 years and expanded it [...]

HTG Molecular Announces Third Statement of Work for New Clinical Assay Development Program

 TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced it has entered into a third statement of work for a new clinical assay development program under its Master Assay Development, Commercialization and Manufacturing Agreement with QIAGEN Manchester Limited, a wholly owned subsidiary of [...]

Access IBO on Knowledge Center